ADAP

Adaptimmune Therapeutics plc ADAP

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ADAP ERNA LNAI BLRX MBRX ANL APLM GOVX LPCN THAR
6M -80.83 % -46.53 % -53.95 % -28.30 % -41.62 % 3.40 % 193.42 % -83.14 % 28.79 % 73.13 %
YTD -92.22 % -76.35 % -53.95 % -70.25 % -91.19 % -37.70 % 54.86 % -93.58 % -12.55 % 13.17 %
1Y -91.75 % -64.40 % -53.95 % -65.88 % -90.98 % -31.53 % 76.24 % -92.80 % -11.46 % 11.00 %
3Y -96.58 % -97.48 % -53.95 % -86.90 % -99.17 % -89.87 % -98.39 % -98.20 % -41.22 % -98.28 %
5Y -99.02 % -99.89 % -53.95 % -97.12 % -99.78 % -89.87 % -98.31 % -99.67 % -82.39 % -99.82 %
10Y -99.51 % -99.97 % -53.95 % -99.62 % -99.98 % -89.87 % -98.31 % -99.64 % -98.05 % -99.82 %
From the beginning -99.70 % -100.00 % -53.95 % -99.91 % -99.98 % -89.87 % -98.31 % -99.64 % -97.50 % -99.82 %

Dividend